The global market for Allergy Diagnostics was valued at US$4.7 Billion in 2024 and is projected to reach US$8.3 Billion by 2030, growing at a CAGR of 10.0% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Technological advancements have significantly improved the accuracy, efficiency, and convenience of allergy diagnostics. Modern diagnostic techniques leverage advanced immunoassays and molecular diagnostics to detect specific allergen components, offering a more detailed understanding of allergic sensitivities. Multiplex testing platforms allow for the simultaneous analysis of multiple allergens from a single blood sample, enhancing the comprehensiveness of diagnostic evaluations. Furthermore, innovations in point-of-care testing enable rapid and on-site allergy assessments, providing immediate results and facilitating timely clinical decisions. These advancements are particularly beneficial in pediatric allergy diagnostics, where non-invasive and quick procedures are preferred. The integration of digital health tools, such as electronic health records (EHRs) and mobile health applications also supports allergy diagnostics by streamlining data management, improving patient monitoring, and enhancing communication between patients and healthcare providers.
The growth in the allergy diagnostics market is driven by several factors, including the increasing prevalence of allergic diseases, rising awareness about allergy management, and advancements in diagnostic technologies. The global burden of allergic conditions, such as asthma, allergic rhinitis, and food allergies, is on the rise, necessitating effective diagnostic solutions to manage and treat these conditions. Growing public awareness and education about allergies have led to higher demand for diagnostic testing, as more individuals seek to identify and manage their allergic triggers. Technological innovations have made allergy diagnostics more accessible and accurate, encouraging healthcare providers to adopt these advanced tools in clinical practice. Additionally, supportive government initiatives and healthcare policies aimed at improving allergy care and management are bolstering market growth. The expansion of healthcare infrastructure and increased investment in research and development further contribute to the market's positive trajectory. As these trends continue, the allergy diagnostics market is poised for significant growth, driven by the ongoing need for precise, efficient, and patient-centric diagnostic solutions.
Global Allergy Diagnostics Market - Key Trends & Drivers Summarized
Allergy diagnostics encompasses a range of tests and procedures used to identify allergic reactions and pinpoint specific allergens responsible for these reactions. Allergies occur when the immune system reacts to foreign substances, such as pollen, food, or pet dander, which are typically harmless to most people. The primary methods of allergy diagnostics include skin tests, blood tests, and challenge tests. Skin tests, such as prick tests or intradermal tests, involve exposing the skin to potential allergens and observing the reaction. Blood tests, like the radioallergosorbent test (RAST) and enzyme-linked immunosorbent assay (ELISA), measure the presence of specific antibodies (IgE) that the immune system produces in response to allergens. Challenge tests are conducted under medical supervision and involve introducing small amounts of allergens to the patient and monitoring for adverse reactions. These diagnostic tools are crucial for accurately diagnosing allergies and devising appropriate management and treatment plans.Technological advancements have significantly improved the accuracy, efficiency, and convenience of allergy diagnostics. Modern diagnostic techniques leverage advanced immunoassays and molecular diagnostics to detect specific allergen components, offering a more detailed understanding of allergic sensitivities. Multiplex testing platforms allow for the simultaneous analysis of multiple allergens from a single blood sample, enhancing the comprehensiveness of diagnostic evaluations. Furthermore, innovations in point-of-care testing enable rapid and on-site allergy assessments, providing immediate results and facilitating timely clinical decisions. These advancements are particularly beneficial in pediatric allergy diagnostics, where non-invasive and quick procedures are preferred. The integration of digital health tools, such as electronic health records (EHRs) and mobile health applications also supports allergy diagnostics by streamlining data management, improving patient monitoring, and enhancing communication between patients and healthcare providers.
The growth in the allergy diagnostics market is driven by several factors, including the increasing prevalence of allergic diseases, rising awareness about allergy management, and advancements in diagnostic technologies. The global burden of allergic conditions, such as asthma, allergic rhinitis, and food allergies, is on the rise, necessitating effective diagnostic solutions to manage and treat these conditions. Growing public awareness and education about allergies have led to higher demand for diagnostic testing, as more individuals seek to identify and manage their allergic triggers. Technological innovations have made allergy diagnostics more accessible and accurate, encouraging healthcare providers to adopt these advanced tools in clinical practice. Additionally, supportive government initiatives and healthcare policies aimed at improving allergy care and management are bolstering market growth. The expansion of healthcare infrastructure and increased investment in research and development further contribute to the market's positive trajectory. As these trends continue, the allergy diagnostics market is poised for significant growth, driven by the ongoing need for precise, efficient, and patient-centric diagnostic solutions.
Scope of the Study
The report analyzes the Allergy Diagnostics market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments:
Product (Assay Kits, Instruments, Services); Allergens (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens); End-Use (Hospitals, Diagnostic Laboratories, Other End-Uses).Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.Key Insights:
- Market Growth: Understand the significant growth trajectory of the Allergy Diagnostics Assay Kits segment, which is expected to reach US$4.5 Billion by 2030 with a CAGR of a 10.7%. The Allergy Diagnostics Instruments segment is also set to grow at 9.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $1.6 Billion in 2024, and China, forecasted to grow at an impressive 14.5% CAGR to reach $1.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as 3M Company, Bausch & Lomb, Inc., ACON Laboratories, Inc., Awareness Technology, Inc., ALK-Abello A/S and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Allergy Diagnostics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Allergy Diagnostics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Allergy Diagnostics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Some of the 100 major companies featured in this Allergy Diagnostics market report include:
- 3M Company
- Bausch & Lomb, Inc.
- ACON Laboratories, Inc.
- Awareness Technology, Inc.
- ALK-Abello A/S
- Allergy Therapeutics Plc
- Alpha Laboratories Ltd.
- Angsana Molecular & Diagnostics Laboratory Pte Ltd.
- Bausch Health Companies Inc.
- Alkor Bio Group
- ALLERGOPHARMA GmbH & Co. KG
- AESKU.Diagnostics GmbH & Co. KG
- AllerGenis, Inc.
- Astra Biotech GmbH
- Assure Tech. (Hangzhou) Co., Ltd
Table of Contents
I. METHODOLOGYMII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Company
- Bausch & Lomb, Inc.
- ACON Laboratories, Inc.
- Awareness Technology, Inc.
- ALK-Abello A/S
- Allergy Therapeutics Plc
- Alpha Laboratories Ltd.
- Angsana Molecular & Diagnostics Laboratory Pte Ltd.
- Bausch Health Companies Inc.
- Alkor Bio Group
- ALLERGOPHARMA GmbH & Co. KG
- AESKU.Diagnostics GmbH & Co. KG
- AllerGenis, Inc.
- Astra Biotech GmbH
- Assure Tech. (Hangzhou) Co., Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 638 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 4.7 Billion |
| Forecasted Market Value ( USD | $ 8.3 Billion |
| Compound Annual Growth Rate | 10.0% |
| Regions Covered | Global |
